Photodynamic therapy for subretinal new vessels.
Photodynamic therapy (PDT) involves the induction of endothelial cell death or occlusion of blood vessels. On the basis of this mechanism of action, PDT is used in the treatment of predominant classic choroidal neovascularization (CNV), if the classic component is over 50%, and in myopic CNV. This study describes 2 cases of distinctive, abnormal, large, subretinal new vessels that are thought to have originated from the choroids. Diminishment of the new vessels was observed following treatment with PDT.
Lee
Sung Chul
SC
Department of Ophthalmology, Yonsei University College of Medicine, 134 Sinchon-Dong, Seodaemun-Gu, Seoul, Korea. sunglee@yumc.yonsei.ac.kr
Bae
Jeong Hun
JH
Koh
Hyung Jun
HJ
Kim
Sung Soo
SS
Kwon
Oh Woong
OW
D000792:Angiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000473:pathology; D010778:Photochemotherapy; D012164:Retinal Diseases / Q000188:drug therapy* / Q000473:pathology; D012171:Retinal Vessels / Q000187:drug effects / Q000473:pathology*